CoChat

Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer

Open access
Miyahara, Yoshihiro, Odunsi, Kunle, Chen, Wenhao, Peng, Guangyong, Matsuzaki, Junko, Wang, Rong-Fu · 2008 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Despite the important role of Th17 cells in the pathogenesis of many autoimmune diseases, their prevalence and the mechanisms by which they are generated and regulated in cancer remain unclear. Here, we report the presence of a high percentage of CD4(+) Th17 cells at sites of ovarian cancer, compared with a low percentage of Th17 cells in peripheral blood mononuclear cells from healthy donors and cancer patients. Analysis of cytokine production profiles revealed that ovarian tumor cells, tumor-derived fibroblasts, and antigen-presenting cells (APCs) secreted several key cytokines including IL-1beta, IL-6, TNF-alpha and TGF-beta, which formed a cytokine milieu that regulated and expanded human IL-17-producing T-helper (Th17) cells. We further show that IL-1beta was critically required for the differentiation and expansion of human Th17 cells, whereas IL-6 and IL-23 may also play a role in the expansion of memory Th17 cells, even though IL-23 levels are low or undetectable in ovarian cancer. Further experiments demonstrated that coculture of naïve or memory CD4(+) T cells with tumor cells, APCs, or both could generate high percentages of Th17 cells. Treatment with anti-IL-1 alone or a combination of anti-IL-1 and anti-IL-6 reduced the ability of tumor cells to expand memory Th17 cells. Thus, we have identified a set of key cytokines secreted by ovarian tumor cells and tumor-associated APCs that favor the generation and expansion of human Th17 cells. These findings should accelerate efforts to define the function of this important subset of CD4(+) T cells in the human immune response to cancer.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0710686105

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 281

Metadata

Authors
Miyahara, Y., Odunsi, K., Chen, W., Peng, G., Matsuzaki, J., & Wang, R.-F.
Affiliations
  • Baylor College of Medicine (US)
  • Roswell Park Comprehensive Cancer Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2008-10-07
Volume
105
Issue
40
Pages
15505-15510
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1967824941
Cited by
279
References
39
Citations by year
2026: 1 · 2025: 9 · 2024: 7 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 18 · 2019: 11 · 2018: 7 · 2017: 14 · 2016: 12 · 2015: 14 · 2014: 20 · 2013: 28 · 2012: 30
FWCI
10.71
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research Institute
  • National Institutes of Health
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
Th17 cells, IL-17, ovarian cancer, CD4+ T cells, tumor microenvironment, IL-1β, interleukin-6, IL-23, TGF-beta, TNF-α, anti-IL-1 therapy, IL-6 inhibition, T cell differentiation
MeSH terms
Cells, Cultured, Female, Humans, Ovarian Neoplasms, CD4-Positive T-Lymphocytes, Interleukin-6, T-Lymphocyte Subsets, Interleukin-17, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.